510(k) Report

510(k) · Cleared

Cleared

EZ LDL Cholesterol Test System

K993741510(k) TraditionalCleared Jul 3, 2000242-day reviewClass I21 CFR 862.1475

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Sigma Diagnostics, Inc. · MRR System, Test, Low Density, Lipoprotein

Cleared on Jul 3, 2000 as substantially equivalent to K982271 (Wako Chemicals USA, Inc., 1998) after a 242-day review. Its family tree reaches back 1 generation to 1998.

Decided
Jul 3, 2000
Review
242 days
Class
Class I
Product code
MRR
Recalls
None
Predicates
1

Its longest line of descent runs back 1 generation to K982271 (1998). No later device cites it as a predicate yet.

K982271 · Wako Direct LDL-C · Wako Chemicals USA, Inc. · 19981996199820002002
K982271 · Wako Direct LDL-C · Wako Chemicals USA, Inc. · 19980
  1. Root · 1 generation backK982271 Wako Direct LDL-CWako Chemicals USA, Inc. · 1998
  2. This deviceK993741 EZ LDL Cholesterol Test SystemSigma Diagnostics, Inc. · 2000
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K982271Wako Direct LDL-CWako Chemicals USA, Inc.1998—
0 (this device)K993741EZ LDL Cholesterol Test SystemSigma Diagnostics, Inc.2000—
FIG. 1 — Lineage of K993741, 1998–2000Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in MRR? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new MRR device

  1. #1 K241800 Atellica® CH HDL Cholesterol (HDLC)& Atellica®…score 8.0 · 2 generations · no Class I recall
  2. #2 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K982271Wako Direct LDL-C
Summary page 1
…ol test system (Procedure No. 358) is substantially equivalent to, and are the same product as the Wako Chemical USA, Inc. Direct LDL-C test system cleared by the FDA as K982271. References 1. Burtis CA, Ashwood ER: Ed Teitz Textbook of Clinical Chemistry, 2" Ed, Saunders, Philadelphia, 1994 2. Rifai N,…
Wako Chemicals USA, Inc.1998—

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Its one ancestor has no recall.

How does its category compare?

All MRR devices

MRR System, Test, Low Density, Lipoprotein: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · MRR

1in 2024

2008: 12009: 22017: 12023: 12024: 1
2007high 2 (2009) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · MRR

Too few MRR 510(k)s in any year since 2007 to give a median.

Recalls per year · MRR

1in 2025

2008: 22018: 12025: 1
2007high 2 (2008) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · MRR

1in 2024

2011: 32017: 32018: 22020: 12021: 12022: 12023: 12024: 1
2007high 3 (2011) · low 0 (2007)2025

MAUDE reports naming product code MRR, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20081—20
20092—00
20100—00
20110—03
20120—00
20130—00
20140—00
20150—00
20160—00
20171—03
20180—12
20190—00
20200—01
20210—01
20220—01
20231—01
20241—01
20250—10
20260—0—

What is it indicated for?

The Sigma Diagnostics EZ™ LDL- cholesterol test system is a device intended to measure LDL-cholesterol in plasma and serum. Cholesterol measurements are used in the diagnosis and treatment of disorders involving excess cholesterol in the blood and lipid and lipoprotein metabolism disorders.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K993741: EZ LDL Cholesterol Test System.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K993741

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026